Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Novartis
Baxter
Cantor Fitzgerald
Merck
QuintilesIMS
US Army
Daiichi Sankyo
Queensland Health
Covington

Generated: December 11, 2017

DrugPatentWatch Database Preview

NIZATIDINE Drug Profile

« Back to Dashboard

When do Nizatidine patents expire, and when can generic versions of Nizatidine launch?

Nizatidine is a drug marketed by Ani Pharms Inc, Apotex Inc, Dr Reddys Labs Ltd, Glenmark Generics, Mylan Pharms Inc, Sandoz, Watson Labs, and Amneal Pharms. and is included in ten NDAs.

The generic ingredient in NIZATIDINE is nizatidine. There are seven drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the nizatidine profile page.
Drug patent expirations by year for NIZATIDINE

Pharmacology for NIZATIDINE

Medical Subject Heading (MeSH) Categories for NIZATIDINE

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Ani Pharms IncNIZATIDINEnizatidineCAPSULE;ORAL075461-001Jul 8, 2002DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Watson LabsNIZATIDINEnizatidineCAPSULE;ORAL075616-002Jul 9, 2002ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Dr Reddys Labs LtdNIZATIDINEnizatidineCAPSULE;ORAL077314-001Sep 15, 2005ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Ani Pharms IncNIZATIDINEnizatidineCAPSULE;ORAL075668-002Sep 12, 2002ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Mylan Pharms IncNIZATIDINEnizatidineCAPSULE;ORAL075934-001Jul 9, 2002DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Dr Reddys Labs LtdNIZATIDINEnizatidineCAPSULE;ORAL077314-002Sep 15, 2005ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Amneal PharmsNIZATIDINEnizatidineSOLUTION;ORAL090576-001Nov 18, 2009RXNoYes► Subscribe► Subscribe► Subscribe► Subscribe
SandozNIZATIDINEnizatidineCAPSULE;ORAL076178-002Jul 5, 2002ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Mylan Pharms IncNIZATIDINEnizatidineCAPSULE;ORAL075934-002Jul 9, 2002DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Ani Pharms IncNIZATIDINEnizatidineCAPSULE;ORAL075668-001Sep 12, 2002ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Novartis
Citi
Federal Trade Commission
McKinsey
McKesson
Colorcon
US Department of Justice
Deloitte
Accenture
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot